en

PRODUCT DETAIL

Dasatinib Zentiva 50 mg filmom obalené tablety

Code 2528D
MA number 44/0296/19-S
Product Form: tbl flm 60x50 mg (fľ.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Zentiva, k.s., Czechia
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA02 Dasatinib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 30.09.2019
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Dasatinib Zentiva 50 mg filmom obalené tablety_12.2022.pdf  
PIL: PIL_Dasatinib Zentiva 50 mg filmom obalené tablety_12.2022.pdf  
Safety feature Yes
Data update: 15.02.2024
eu-flag.png sk-flag.png